Comments
Lupin has launched Methylergonovine Maleate tablets, used for the prevention and control of postpartum hemorrhage, in the American market.
The company said in a statement that it has launched the product after having earlier received approval from the US Food and Drug Administration (USFDA).
Lupin’s product is the generic equivalent of Novartis Pharmaceuticals Corp’s Methergine which is indicated for the prevention and control of postpartum hemorrhage. As per the latest industry estimates, Methylergonovine Maleate tablets had annual sales of around $71.5 million in the US.
Lupin shares were trading 1.18 per cent up at Rs 772.10 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.